Stocks and Investing
by (remove) : Leland Gershell
RSSJSONXMLCSV
Stocks and Investing
by (remove) : Leland Gershell
RSSJSONXMLCSV
Thu, October 3, 2024
Wed, September 25, 2024
Mon, September 23, 2024
Tue, September 17, 2024
Thu, September 5, 2024
Mon, August 12, 2024
Fri, July 26, 2024
Tue, July 23, 2024
Wed, July 10, 2024
Fri, June 14, 2024
Fri, May 17, 2024
Tue, May 14, 2024
Thu, May 9, 2024
Mon, April 22, 2024
Tue, April 16, 2024
Mon, April 15, 2024
Mon, April 1, 2024
Thu, March 28, 2024
Thu, March 21, 2024
Fri, March 15, 2024
Tue, December 19, 2023
Wed, November 15, 2023
Mon, November 13, 2023
Wed, October 11, 2023
Wed, August 9, 2023
Tue, June 27, 2023
Tue, May 16, 2023
Mon, May 15, 2023

Leland Gershell Initiated (BBIO) at Hold on, Oct 3rd, 2024


Published on 2024-10-28 14:38:21 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Initiated "BridgeBio Pharma, Inc." (BBIO) at Hold on, Oct 3rd, 2024.

Leland has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 0 agree with Leland's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Leland


  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $43 on, Wednesday, October 2nd, 2024
  • Josh Schimmer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $70 on, Monday, September 16th, 2024
  • Geoff Meacham of "B of A Securities" Maintained at Strong Buy and Held Target at $42 on, Wednesday, September 11th, 2024
  • Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $46 on, Wednesday, September 4th, 2024
  • Cory Kasimov of "Evercore ISI Group" Maintained at Buy with Decreased Target to $45 on, Wednesday, August 7th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $43 on, Wednesday, August 7th, 2024
Contributing Sources